Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -358,000 | -330,600 | -100 | -127,300 | -84,800 |
| Depreciation Amortization | 357,800 | 345,200 | 14,400 | 117,800 | 60,000 |
| Income taxes - deferred | 0 | 0 | N/A | -2,800 | -3,000 |
| Accounts receivable | 3,600 | -15,400 | 800 | -8,700 | -12,700 |
| Accounts payable and accrued liabilities | 2,800 | 3,600 | 0 | 4,700 | 5,800 |
| Other Working Capital | -17,700 | -39,100 | -12,100 | -54,400 | -30,200 |
| Other Operating Activity | 2,700 | 6,400 | -19,300 | 62,000 | 49,600 |
| Operating Cash Flow | $-8,800 | $-29,900 | $-16,300 | $-8,700 | $-15,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,900 | -8,100 | -5,300 | -19,000 | -6,600 |
| Net Acquisitions | N/A | N/A | N/A | 8,800 | N/A |
| Sale Of Investment | 0 | 0 | 0 | 9,000 | 9,000 |
| Purchase Sale Intangibles | -10,500 | -7,100 | -3,000 | -10,700 | -8,400 |
| Other Investing Activity | -10,500 | -7,100 | -3,000 | -10,700 | -8,400 |
| Investing Cash Flow | $-21,400 | $-15,200 | $-8,300 | $-11,900 | $-6,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 165,000 | 40,000 | 40,000 | 120,000 | 100,000 |
| Debt Repayment | -80,800 | -20,700 | -20,600 | -119,900 | -100,300 |
| Common Stock Issued | 2,700 | 2,700 | N/A | 5,900 | 3,000 |
| Other Financing Activity | -14,500 | -5,800 | -5,800 | -13,400 | -12,200 |
| Financing Cash Flow | $72,400 | $16,200 | $13,600 | $-7,400 | $-9,500 |
| Exchange Rate Effect | 700 | 700 | 100 | -1,000 | -300 |
| Beginning Cash Position | 111,900 | 111,900 | 111,900 | 140,900 | 140,900 |
| End Cash Position | 154,800 | 83,700 | 101,000 | 111,900 | 109,800 |
| Net Cash Flow | $42,900 | $-28,200 | $-10,900 | $-29,000 | $-31,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,800 | -29,900 | -16,300 | -8,700 | -15,300 |
| Capital Expenditure | -10,900 | -8,100 | -5,300 | -19,000 | -15,400 |
| Free Cash Flow | -19,700 | -38,000 | -21,600 | -27,700 | -30,700 |